These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Mathé G, Weiner R, Pouillart P, Schwarzenberg L, Jasmin C, Schneider M, Hayat M, Amiel JL, de Vassal F, Rosenfeld C. Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314 [No Abstract] [Full Text] [Related]
3. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man. Mathé G, Hayat M, Amiel JL, Schwarzenberg L, Schneider M, Pouillart P, Cattan A. Boll Ist Sieroter Milan; 1971 Dec; 50(4):251-9. PubMed ID: 5293498 [No Abstract] [Full Text] [Related]
4. Approaches to the treatment of acute leukemia and lymphoma in adults. Bodey GP, Rodriguez V. Semin Hematol; 1978 Jul; 15(3):221-61. PubMed ID: 353991 [No Abstract] [Full Text] [Related]
5. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor]. Mathé G. Rev Fr Etud Clin Biol; 1968 Nov; 13(9):881-3. PubMed ID: 5304470 [No Abstract] [Full Text] [Related]
6. New experimental and clinical data on leukaemia immunotherapy. Mathé G, Schwarzenberg L, Amiel JL, Pouillart P, Hayat M, de Vassal F, Rosenfeld C, Jasmin C. Proc R Soc Med; 1975 Apr; 68(4):211-6. PubMed ID: 1060146 [Abstract] [Full Text] [Related]
7. Immunological approaches of leukaemia treatment. Mathé G. Ann Inst Pasteur (Paris); 1972 Apr; 122(4):855-81. PubMed ID: 4559238 [No Abstract] [Full Text] [Related]
8. Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man. Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Pouillart P, Cattan A. Bibl Haematol; 1970 Apr; (36):678-88. PubMed ID: 5293620 [No Abstract] [Full Text] [Related]
9. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine. Kataoka T, Akahori Y, Sakurai Y. Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896 [Abstract] [Full Text] [Related]
10. [Current treatment of acute leukemias]. Sans-Sabrafen J. Med Clin (Barc); 1981 Mar 25; 76(6):275-8. PubMed ID: 7019595 [No Abstract] [Full Text] [Related]
11. [Treatment of acute leukemia]. Barry A, Delage JM. Union Med Can; 1970 Jun 25; 99(6):1045-54. PubMed ID: 5280031 [No Abstract] [Full Text] [Related]
12. [Immunotherapy of leukemia--a realistic clinical possibility?]. Gahrton G. Lakartidningen; 1971 Mar 31; 68(14):1601-8. PubMed ID: 4930453 [No Abstract] [Full Text] [Related]
13. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer. Mathé G, Halle-Pannenko O, Bourut C, Hiu IJ. Johns Hopkins Med J Suppl; 1974 Mar 31; 3():85-102. PubMed ID: 4154074 [No Abstract] [Full Text] [Related]
17. [Treatment of acute lymphoblastic leukemia in children during remission with a sequential chemotherapy followed by an active immunotherapy trial]. Mathe G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schulumberger JR. Arch Fr Pediatr; 1968 Mar 31; 25(6):639-50. PubMed ID: 5245426 [No Abstract] [Full Text] [Related]